Genome & Company, with a market cap of USD 280 million, is the highest valued microbiome company worldwide. Dr Jisoo Pae, its co-founder and CEO,…

Johnsee Lee and Eric Yang of Taiwanese precision medicine diagnostics firm Quark Biosciences outline their technology’s unique characteristics, how…

István Peták, co-founder and CEO of Oncompass introduces the innovative start-up and elaborates on how its solution for digital treatment planning…

Li Qing of Illumina China discusses his recent move to the company, the strategic significance of the China market to Illumina global, and the…

Mengchu Wu, CEO of Health Genetech, introduces the innovative precision medicine company as it prepares to transition from a research-positioned…

Dr Jeffery Tzen, president of the Taiwanese Society of Molecular Medicine and precision medicine key opinion leader, offers insights into Taiwan’s…

Eric Yang, secretary general of the Taiwan Precision Medical and Molecular Diagnostics Industry Association (PMMD), speaks about the key challenges…

Amy Van Buskirk, general manager of Roche Sweden, discusses the role Roche plays in the Swedish healthcare system, how Sweden is becoming an…

In this exclusive and wide-ranging interview, Janssen’s EMEA head Kris Sterkens outlines the company’s strategies in Europe, its increasing…

Dr John Gong, CEO of 3D Medicines, shares the company’s ‘3D – diagnostics, data, and drug development’ approach to cancer precision medicine;…

Axel Schumacher, co-founder and chief scientific officer of Shivom, a data-driven next generation precision-medicine company in the blockchain space,…

This week the NHS becomes the first in the world to routinely offer access to breakthrough genomic medicine. Today (1st October 2018) marks a huge…